Loading…
Biotech Next Gen 2021 has ended
MW

Matthew White

Osborne Clarke LLP
Associate
London
Websitehttps://osborneclarke.com/lawyers/matthew-white/
Contact Me
LinkedIn on LinkedIn
I am an Associate working in Osborne Clarke's Intellectual Property Disputes group. I advise clients across a broad range of issues, with a particular focus on patent litigation in the life sciences industry.  
Tuesday, June 22
 

9:30am EDT

What's next in gene therapy Virtual

10:30am EDT

Digital Acceleration: Using Data and Technology to Solve Some of Health Care’s Toughest Challenges Virtual

10:50am EDT

Executive Interview: Dave Lennon, President, Novartis Gene Therapies Virtual

11:00am EDT

Enabling base editing research via automation and a cloud connected lab Virtual

11:25am EDT

Executive Interview: Marcio Souza, CEO, Praxis Precision Medicines Virtual
 
Wednesday, June 23
 

9:00am EDT

Open for Networking

9:30am EDT

New trends shaping biopharma manufacturing Virtual

10:25am EDT

The New Path to Market for Emerging Biotech Virtual

10:50am EDT

Manufacturing of new modalities: New opportunities come with new challenges Virtual

11:05am EDT

Executive Interview: Sebastian Guth, Ph.D., President, Americas Region, Bayer Pharmaceuticals & Brian Cantwell, Vice President, Digital Strategy, Bayer Pharmaceuticals Virtual

11:30am EDT

Modernizing the delivery of healthcare with Chrome Enterprise Virtual

11:50am EDT

Executive Interview: Ardy Arianpour, CEO and Co-Founder, Seqster Virtual

12:00pm EDT

Who's next in biotech and pharma? Virtual